Alexza Pharma (ALXA) Volatility Up; Shares Rip Higher on ADASUVE NDA Resubmission

June 22, 2012 10:01 AM EDT
Alexza Pharmaceuticals (Nasdaq: ALXA) volatility is up as share rip higher Friday morning following resubmission of its ADASUVE New Drug Application to the U.S. FDA in response to a Complete Response Letter (CRL) received in May 2012.

Volatility is up 5.5 percent from yesterday's close. Shares are up 42 percent on the session.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog, Momentum Movers, Options

Add Your Comment